 |
Also known as: Synagis
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Palivizumab.
No reviews have yet been submitted. Be the first to review this drug.
Impact of Unapproved Dosing of RSV Immunoprophylaxis Presented at Pediatric Academic Societies' Annual Meeting BOSTON, May 1, 2012 /PRNewswire/ -- MedImmune,...
Apr 24, 2012 - MicroDose Therapeutx, Inc. announced today that it has concluded the second of two Phase I studies with its novel inhaled antiviral fusion...
Many pediatric hospital admissions involve a common virus that infects the lungs and airways and can lead to serious illness in young children and people with...
Looking for answers? Ask a question or go join the palivizumab support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Apr 16th, 2012), Cerner Multum™ (updated May 18th, 2012), Wolters Kluwer™ (updated Apr 29th, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
